Works matching IS 2160763X AND DT 2018 AND VI 7 AND IP 8

Results: 14

Pharmacokinetics, Excretion, and Mass Balance of [<sup>14</sup>C]‐Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 901, doi. 10.1002/cpdd.616

By:

Ambery, Claire;
Young, Graeme;
Fuller, Teresa;
Lazaar, Aili L.;
Pereira, Adrian;
Hughes, Adam;
Ramsay, David;
den Berg, Frans;
Daley‐Yates, Peter

Publication type:

Article

Assessment of the Effects of Age and Renal Function on Pharmacokinetics of Bazedoxifene in Postmenopausal Women.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 920, doi. 10.1002/cpdd.607

By:

McKeand, William;
Ermer, James;
Korth‐Bradley, Joan

Publication type:

Article

Amenamevir: Studies of Potential CYP3A‐Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 844, doi. 10.1002/cpdd.586

By:

Adeloye, Temitope;
Sahgal, Omair;
Puri, Adeep;
Warrington, Steve;
Endo, Takamasa;
Dennison, Jeremy;
Johnston, Atholl

Publication type:

Article

Amenamevir: Studies of Potential CYP2C8‐ and CYP2B6‐Mediated Pharmacokinetic Interactions With Montelukast and Bupropion in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 860, doi. 10.1002/cpdd.578

By:

Dennison, Jeremy;
Puri, Adeep;
Warrington, Steven;
Endo, Takamasa;
Adeloye, Temitope;
Johnston, Atholl

Publication type:

Article

Effects of Intrinsic Factors on the Clinical Pharmacokinetics of Vortioxetine.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 880, doi. 10.1002/cpdd.577

By:

Chen, Grace;
Nomikos, George G.;
Affinito, John;
Jacobson, William;
Zhao, Zhen;
Wang, Shining;
Xie, Jinhui

Publication type:

Article

A Study of the Potential Interaction Between Bazedoxifene and Atorvastatin in Healthy Postmenopausal Women.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 911, doi. 10.1002/cpdd.458

By:

McKeand, William;
Baird‐Bellaire, Susan;
Ermer, James;
Patat, Alain

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 820, doi. 10.1002/cpdd.456

By:

Samukawa, Yoshishige;
Haneda, Masakazu;
Seino, Yutaka;
Sasaki, Takashi;
Fukatsu, Atsushi;
Kubo, Yusuke;
Sato, Yuri;
Sakai, Soichi

Publication type:

Article

Bioequivalence of Canakinumab Injected Subcutaneously via an Autoinjector Device or a Prefilled Safety Syringe Device in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 829, doi. 10.1002/cpdd.455

By:

Anumolu, SivaNaga S.;
Lindgren, Sam;
Vemula, Janardhana;
Floch, David;
Reynolds, Christine;
Wallny, Hans‐Joachim;
Sun, Haiying

Publication type:

Article

Ropivacaine Wound Infiltration for Pain Management After Breast Cancer Mastectomy: A Population Pharmacokinetic Analysis.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 811, doi. 10.1002/cpdd.452

By:

Riff, Camille;
Guilhaumou, Romain;
Marsot, Amelie;
Beaussier, Marc;
Cohen, Monique;
Blin, Olivier;
Francon, Daniel

Publication type:

Article

Confirmation of the Cardiac Safety of PGF<sub>2α</sub> Receptor Antagonist OBE022 in a First‐in‐Human Study in Healthy Subjects, Using Intensive ECG Assessments.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 889, doi. 10.1002/cpdd.447

By:

Täubel, Jörg;
Lorch, Ulrike;
Coates, Simon;
Fernandes, Sara;
Foley, Paul;
Ferber, Georg;
Gotteland, Jean‐Pierre;
Pohl, Oliver

Publication type:

Article

Risk Factor for Diabetes Mellitus and High Blood Glucose With HMG‐CoA Reductase Inhibitors Using a Postmarketing Surveillance Database in Japan.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 800, doi. 10.1002/cpdd.444

By:

Hashiguchi, Masayuki;
Maruyama, Junya;
Shimizu, Mikiko;
Takahashi, Daichi;
Shiga, Tsuyoshi

Publication type:

Article

Comparison of Changes in the Lipid Profiles of Eastern Chinese Postmenopausal Women With Early‐Stage Breast Cancer Treated With Different Aromatase Inhibitors: A Retrospective Study.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 837, doi. 10.1002/cpdd.420

By:

Tian, Wei;
Wu, Miaowei;
Deng, Yongchuan

Publication type:

Article

A Prospective Randomized, Double‐Blind, Two‐Period Crossover Pharmacokinetic Trial Comparing Green Coffee Bean Extract—A Botanically Sourced Caffeine—With a Synthetic USP Control.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 871, doi. 10.1002/cpdd.451

By:

Morton, Kayce;
Knight, Katelin;
Kalman, Douglas;
Hewlings, Susan

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 795, doi. 10.1002/cpdd.405
Publication type:: Article